Transgene SA (EPA: TNG)
France
· Delayed Price · Currency is EUR 1.130
+0.010 (0.89%)
Aug 30, 2024, 5:35 PM CET
Transgene Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 13.03 | 0.76 | 19.17 | 30.35 | 51.06 | 15.19 | Upgrade
|
| Other Revenue | 6.61 | 8.44 | 6.55 | 8.25 | 8.51 | 7.8 | Upgrade
|
| Revenue | 19.64 | 9.19 | 25.72 | 38.6 | 59.56 | 22.99 | Upgrade
|
| Revenue Growth (YoY) | -20.70% | -64.26% | -33.35% | -35.20% | 159.09% | 7.27% | Upgrade
|
| Cost of Revenue | 0.74 | 0.74 | 1.77 | 1.84 | 1.95 | 11.39 | Upgrade
|
| Gross Profit | 18.9 | 8.46 | 23.95 | 36.75 | 57.61 | 11.6 | Upgrade
|
| Selling, General & Admin | 16.88 | 16.81 | 17.49 | 22.88 | 22.51 | 43.02 | Upgrade
|
| Research & Development | 89.87 | 87.65 | 97.5 | 117.84 | 77.05 | 92.04 | Upgrade
|
| Other Operating Expenses | -0 | 0.8 | -1.38 | -0.49 | 0.36 | 0.09 | Upgrade
|
| Operating Expenses | 106.75 | 105.26 | 113.62 | 140.23 | 99.92 | 135.15 | Upgrade
|
| Operating Income | -87.86 | -96.8 | -89.67 | -103.48 | -42.31 | -123.55 | Upgrade
|
| Interest Expense | -6.68 | -5.31 | -3.79 | -4.17 | -2.41 | -2.61 | Upgrade
|
| Interest & Investment Income | 6.86 | 3.61 | 1.12 | 0.72 | 1.39 | 6.99 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | 4.22 | 6.06 | 9.74 | -10.59 | 3.81 | Upgrade
|
| Other Non Operating Income (Expenses) | 29.53 | -1.12 | -12.33 | 0.44 | 0.34 | 0.15 | Upgrade
|
| EBT Excluding Unusual Items | -58.18 | -95.4 | -98.6 | -96.75 | -53.58 | -115.21 | Upgrade
|
| Gain (Loss) on Sale of Investments | -20.57 | -20.57 | - | - | - | - | Upgrade
|
| Legal Settlements | -0.5 | -0.5 | - | - | - | - | Upgrade
|
| Pretax Income | -79.25 | -116.46 | -98.6 | -96.75 | -53.58 | -115.21 | Upgrade
|
| Income Tax Expense | -0.34 | 0.37 | 0.09 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -78.91 | -116.84 | -98.69 | -96.75 | -53.58 | -115.21 | Upgrade
|
| Earnings From Discontinued Operations | - | 8.39 | -15.35 | -28.36 | -43.9 | - | Upgrade
|
| Net Income to Company | -78.91 | -108.44 | -114.03 | -125.11 | -97.48 | -115.21 | Upgrade
|
| Minority Interest in Earnings | - | 7.38 | 7.89 | 10.91 | 16.41 | 13.12 | Upgrade
|
| Net Income | -78.91 | -101.06 | -106.14 | -114.2 | -81.07 | -102.09 | Upgrade
|
| Net Income to Common | -78.91 | -101.06 | -106.14 | -114.2 | -81.07 | -102.09 | Upgrade
|
| Shares Outstanding (Basic) | 71 | 57 | 46 | 45 | 43 | 42 | Upgrade
|
| Shares Outstanding (Diluted) | 71 | 57 | 46 | 45 | 43 | 42 | Upgrade
|
| Shares Change (YoY) | 42.59% | 25.17% | 1.62% | 5.45% | 0.14% | 4.09% | Upgrade
|
| EPS (Basic) | -1.12 | -1.77 | -2.33 | -2.55 | -1.91 | -2.41 | Upgrade
|
| EPS (Diluted) | -1.12 | -1.77 | -2.33 | -2.55 | -1.91 | -2.41 | Upgrade
|
| Free Cash Flow | 49.64 | -25.82 | -89.88 | -123.11 | -124.34 | -82.06 | Upgrade
|
| Free Cash Flow Per Share | 0.70 | -0.45 | -1.97 | -2.75 | -2.93 | -1.93 | Upgrade
|
| Gross Margin | 96.25% | 91.98% | 93.11% | 95.22% | 96.72% | 50.45% | Upgrade
|
| Operating Margin | -447.44% | -1053.00% | -348.57% | -268.11% | -71.03% | -537.42% | Upgrade
|
| Profit Margin | -401.86% | -1099.30% | -412.61% | -295.87% | -136.11% | -444.07% | Upgrade
|
| Free Cash Flow Margin | 252.82% | -280.85% | -349.38% | -318.95% | -208.75% | -356.92% | Upgrade
|
| EBITDA | -77.4 | -86.75 | -79.77 | -98.65 | -34.68 | -116.85 | Upgrade
|
| EBITDA Margin | - | - | - | -255.59% | -58.23% | - | Upgrade
|
| D&A For EBITDA | 10.46 | 10.06 | 9.9 | 4.83 | 7.63 | 6.7 | Upgrade
|
| EBIT | -87.86 | -96.8 | -89.67 | -103.48 | -42.31 | -123.55 | Upgrade
|
| EBIT Margin | - | - | - | -268.11% | -71.03% | - | Upgrade
|
| Revenue as Reported | 19.64 | 9.19 | 25.73 | 38.6 | 59.56 | 22.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.